Tumor necrosis factor (TNF)-alpha inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphingomyelinase - PubMed (original) (raw)
. 1996 May 31;271(22):13018-22.
doi: 10.1074/jbc.271.22.13018.
Affiliations
- PMID: 8662983
- DOI: 10.1074/jbc.271.22.13018
Free article
Tumor necrosis factor (TNF)-alpha inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphingomyelinase
P Peraldi et al. J Biol Chem. 1996.
Free article
Abstract
Tumor necrosis factor (TNF)-alpha plays a central role in the state of insulin resistance associated with obesity. It has previously been shown that one important mechanism by which TNF-alpha interferes with insulin signaling is through the serine phosphorylation of insulin receptor substrate-1 (IRS-1), which can then function as an inhibitor of the tyrosine kinase activity of the insulin receptor (IR). However, the receptors and the signaling pathway used by TNF-alpha that mediate the inhibition of IR activity are unknown. We show here that human TNF-alpha, which binds only to the murine p55 TNF receptor (TNFR), is as effective at inhibiting insulin-dependent tyrosine phosphorylation of IR and IRS-1 in adipocytes and myeloid 32D cells as murine TNF-alpha, which binds to both p55 TNFR and p75 TNFR. Likewise, antibodies that are specific agonists for p55 TNFR or p75 TNFR demonstrate that stimulation of p55 TNFR is sufficient to inhibit insulin signaling, though a small effect can also be seen with antibodies to p75 TNFR. Exogenous sphingomyelinase and ceramides, known to be formed by activation of p55 TNFR, inhibit IR and IRS-1 tyrosine phosphorylation and convert IRS-1 into an inhibitor of IR tyrosine kinase in vitro. Myeloid 32D cells expressing IR and IRS-1 are sensitive to this inhibition, but cells expressing IR and IRS-2 are resistant, pointing to an important difference in the biological function between IRS-1 and IRS-2. These data strongly suggest that TNF-alpha inhibits insulin signaling via stimulation of p55 TNFR and sphingomyelinase activity, which results in the production of an inhibitory form of IRS-1.
Similar articles
- Tumor necrosis factor-alpha acutely inhibits insulin signaling in human adipocytes: implication of the p80 tumor necrosis factor receptor.
Liu LS, Spelleken M, Röhrig K, Hauner H, Eckel J. Liu LS, et al. Diabetes. 1998 Apr;47(4):515-22. doi: 10.2337/diabetes.47.4.515. Diabetes. 1998. PMID: 9568681 - Tumor necrosis factor (TNF) interferes with insulin signaling through the p55 TNF receptor death domain.
Csehi SB, Mathieu S, Seifert U, Lange A, Zweyer M, Wernig A, Adam D. Csehi SB, et al. Biochem Biophys Res Commun. 2005 Apr 1;329(1):397-405. doi: 10.1016/j.bbrc.2005.01.140. Biochem Biophys Res Commun. 2005. PMID: 15721320 - IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance.
Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM. Hotamisligil GS, et al. Science. 1996 Feb 2;271(5249):665-8. doi: 10.1126/science.271.5249.665. Science. 1996. PMID: 8571133 - Mechanisms of TNF-alpha-induced insulin resistance.
Hotamisligil GS. Hotamisligil GS. Exp Clin Endocrinol Diabetes. 1999;107(2):119-25. doi: 10.1055/s-0029-1212086. Exp Clin Endocrinol Diabetes. 1999. PMID: 10320052 Review. - Inhibition of insulin receptor signaling by TNF: potential role in obesity and non-insulin-dependent diabetes mellitus.
Skolnik EY, Marcusohn J. Skolnik EY, et al. Cytokine Growth Factor Rev. 1996 Aug;7(2):161-73. doi: 10.1016/1359-6101(96)00021-4. Cytokine Growth Factor Rev. 1996. PMID: 8899294 Review.
Cited by
- Dysregulated mTOR networks in experimental sporadic Alzheimer's disease.
de la Monte SM, Tong M. de la Monte SM, et al. Front Cell Neurosci. 2024 Sep 25;18:1432359. doi: 10.3389/fncel.2024.1432359. eCollection 2024. Front Cell Neurosci. 2024. PMID: 39386180 Free PMC article. - The serine phosphorylations in the IRS-1 PIR domain abrogate IRS-1 and IR interaction.
Woo JR, Bae SH, Wales TE, Engen JR, Lee J, Jang H, Park S. Woo JR, et al. Proc Natl Acad Sci U S A. 2024 Apr 23;121(17):e2401716121. doi: 10.1073/pnas.2401716121. Epub 2024 Apr 16. Proc Natl Acad Sci U S A. 2024. PMID: 38625937 Free PMC article. - Ceramides are fuel gauges on the drive to cardiometabolic disease.
Wilkerson JL, Tatum SM, Holland WL, Summers SA. Wilkerson JL, et al. Physiol Rev. 2024 Jul 1;104(3):1061-1119. doi: 10.1152/physrev.00008.2023. Epub 2024 Feb 1. Physiol Rev. 2024. PMID: 38300524 Review. - Effects of perinatal stress on the metabolites and lipids in plasma of dairy goats.
Huang Y, Kong Y, Li B, Zhao C, Loor JJ, Tan P, Yuan Y, Zeng F, Zhu X, Qi S, Zhao B, Wang J. Huang Y, et al. Stress Biol. 2023 May 12;3(1):11. doi: 10.1007/s44154-023-00088-z. Stress Biol. 2023. PMID: 37676623 Free PMC article. - Functional role of skeletal muscle-derived interleukin-6 and its effects on lipid metabolism.
Lin W, Song H, Shen J, Wang J, Yang Y, Yang Y, Cao J, Xue L, Zhao F, Xiao T, Lin R. Lin W, et al. Front Physiol. 2023 Jul 24;14:1110926. doi: 10.3389/fphys.2023.1110926. eCollection 2023. Front Physiol. 2023. PMID: 37555019 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials